Montelukast + Levocetirizine in Allergies – LCM-DT

Allergic conditions like allergic rhinitis, asthma, and seasonal allergies affect millions of people worldwide. The combination of Montelukast and Levocetirizine provides dual relief by targeting both inflammation and allergy symptoms. A trusted formulation for this therapy is LCM-DT Tablets, designed for effective control of allergies.

How the Combination Works

Montelukast is a leukotriene receptor antagonist that blocks inflammation-causing chemicals, preventing asthma symptoms and nasal congestion. Levocetirizine is a powerful antihistamine that reduces sneezing, runny nose, and itching. Together, they provide comprehensive control over allergic reactions.

Benefits of LCM-DT Tablets

• Relieves symptoms of seasonal and perennial allergic rhinitis.
• Prevents asthma symptoms triggered by allergens.
• Reduces sneezing, nasal congestion, and itching.
• Provides dual relief with anti-inflammatory and antihistamine action.

About LCM-DT

LCM-DT Tablets combine Montelukast and Levocetirizine in a dispersible formulation, making it easy to administer, especially in children and elderly patients. This ensures better compliance and faster relief.

Who Should Use LCM-DT?

Patients suffering from asthma, allergic rhinitis, dust or pollen allergies, and seasonal allergy symptoms benefit from LCM-DT. It is especially useful for those who need long-term allergy control.

Conclusion

For effective management of allergies and asthma-related symptoms, LCM-DT Tablets provide dual relief by combining Montelukast and Levocetirizine in one convenient formulation.